Valeant Pharmaceuticals International Business Analyst Salaries in Anaheim, CA
The average Valeant Pharmaceuticals International Business Analyst in Anaheim, CA earns an estimated $95,857 annually, which includes an estimated base salary of $87,532 with a $8,325 bonus. Valeant Pharmaceuticals International's Business Analyst compensation is $12,386 more than the US average for a Business Analyst. Business Analyst salaries at Valeant Pharmaceuticals International in Anaheim, CA can range from $55,132 - $170,000.
In Anaheim, CA, The Marketing Department at Valeant Pharmaceuticals International earns $10,961 more on average than the Operations Department.
Last updated 2 years ago.
- $87,532
- avg. base
- $8,325
- avg. bonus
Business Analyst Salaries at Valeant Pharmaceuticals International
In Anaheim, CA, Business Analysts earn $2,253 more than Event Planners, and $5,788 less than Marketing Managers.
Compensation at Valeant Pharmaceuticals International by Department
In Anaheim, CA, The Marketing Department averages $10,961 more than the Operations Department, and $4,240 less than the Finance Department
Business Analyst Compensation by Gender (All Companies)
The average female Business Analyst at companies similar size to Valeant Pharmaceuticals International reported making $89,933, while the average male Business Analyst at similar sized companies reported making $93,781.
Business Analyst Compensation by Ethnicity (All Companies)
The average Native American Business Analyst at companies similar size to Valeant Pharmaceuticals International reported making $115,000, while the average African American/Black Business Analyst at similar sized companies reported making $75,705.
How Business Analysts at Valeant Pharmaceuticals International Rate Their Compensation
The majority of Business Analysts at Valeant Pharmaceuticals International believe they're compensated fairly. The vast majority (80%) of Business Analysts at Valeant Pharmaceuticals International are satisfied with their benefits. See more compensation ratings at Valeant Pharmaceuticals International
